Looking Back at 2022 and Looking Forward to 2023
By

As we all know, 2022 presented many challenges to each of us, on many fronts.  From the ebbing yet persistent pandemic, to business disruptions, the lack of equity capital, the Ukraine war and its impacts on supply chains and global food sources, the “good and bad” of hybrid work formats,…Read More

Read More
Managing Cybersecurity Risks: Protecting Against Ransomware
By

In April 2021 my partner at FLG, Fuad Ahmad, wrote a post titled Managing Cybersecurity Risk: The Role of the CFO. His key points remain timely and highly relevant today. In this post I want to address perhaps the most pernicious, rapidly growing, and dangerous threat to Cybersecurity today: Ransomware….Read More

Read More
Changing Business Models: The CFO’s Role When Pivoting for Success
By

As a CEO, when a board member or investor questions the feasibility of your company’s business model, you might be tempted to counter with the pat response “if it ain’t broke, don’t fix it”. But what if your business model IS broken? What should you do then? I work frequently…Read More

Read More
Raising Capital in Life Sciences in 2022-2023: What Works?
By

Raising money in the capital markets for a biopharma or life sciences company over the last few years has been quite a roller coaster ride. Funding among U.S. biotech startups reached a record high of $77 billion in 2021 (Crunchbase), as investors were attracted to expanding opportunities in genetics, therapeutics…Read More

Read More

More Posts